The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan
Andrew Azman and colleagues describe their experience of deploying >250,000 doses of oral cholera vaccine in South Sudan in 2014
Vyšlo v časopise:
The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan. PLoS Med 12(11): e32767. doi:10.1371/journal.pmed.1001901
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001901
Souhrn
Andrew Azman and colleagues describe their experience of deploying >250,000 doses of oral cholera vaccine in South Sudan in 2014
Zdroje
1. United States Agency for International Development. Southern Sudan Health System Assessment. In: healthsystemassessment.com [Internet]. Jul 2007 [cited 27 Apr 2015]. http://www.healthsystemassessment.com/wp-content/uploads/2012/06/Sudan_GAVI_Version_9_08_FIN_.pdf
2. WHO/UNICEF. Joint Monitoring Programme for Water Supply and Sanitation. Progress on Sanitation and Drinking-Water: 2014 Update; World Health Organization: Geneva, Switzerland, 2014.
3. Porta MI, Lenglet A, de Weerdt S, et al. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 108(12):815. doi: 10.1093/trstmh/tru153
4. Yen C, Hyde TB, Costa AJ, et al. The development of global vaccine stockpiles. The Lancet Infectious Diseases 2015;15(3):340–7. doi: 10.1016/S1473-3099(14)70999-5 25661473
5. Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, et al. Feasibility of Mass Vaccination Campaign with Oral Cholera Vaccines in Response to an Outbreak in Guinea. PLoS Med 2013 Sep;10(9):e1001512. doi: 10.1371/journal.pmed.1001512
6. Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. Use of Vibrio cholerae Vaccine in an Outbreak in Guinea. N Engl J Med. 2014 May 29;370(22):2111–20. doi: 10.1056/NEJMoa1312680 24869721
7. Lanata Cf, George Stroh Jr, Black Re, Gonzales H. An Evaluation of Lot Quality Assurance Sampling to Monitor and Improve Immunization Coverage. International Journal of Epidemiology 1990;19(4):1086–90. 2083994
8. Agaba J and Amoli L (2014, May 1). Cholera—One more dead as patients’ toll hits 92. New Vision. http://www.newvision.co.ug/news/655136-cholera-one-more-dead-as-patients-toll-hits-92.html
9. Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Org 2012; 90(3):209–218A. 22461716
10. Azman AS, Lessler J. Reactive vaccination in the presence of disease hotspots. Proceedings of the Royal Society B: Biological Sciences 2015;282(1798):20141341–1. doi: 10.1098/rspb.2014.1341 25392464
11. Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL. Comparative Effectiveness of Different Strategies of Oral Cholera Vaccination in Bangladesh: A Modeling Study. PLoS Negl Trop Dis 2014;8(12):e3343. doi: 10.1371/journal.pntd.0003343 25473851
12. Ivers LC, Charles RC, Hilaire IJ, et al. Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection. J Infect Dis 2015;jiv108.
13. Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study. PLoS Med 2015;12(8):e1001867 doi: 10.1371/journal.pmed.1001867 26305226
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2015 Číslo 11
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies
- The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan
- The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020
- Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa